Categories

Tag: Uncategorized

BLOGS: Health Wonk Review

Welcome to Health Wonk Review. Joe expected some crack about English soccer fans, but I’m all depressed since the Catalans ejected my boys with barely a whimper from the European Champions League we were supposed to win on Tuesday.
 
So onto the review. Every two weeks we’re putting together the best of the health care policy, business and technology posts from around the blogosphere, and the hosting will rotate too. We’re going to start with:
 
Politics, policy and voodoo economics
 
The good boys and girls at Marketplace.MD have been busy. Founder Trapier K. Michael gives credit to the free market for hospital quality information on his new blog, Hayek, MD. Evian at Free Canada tells us how "Liberal health policy" makes Alberta’s premiere want to hurl and throw a Russell-Crowe-type health policy fit. And David of Medical Liberty looks at Dr. Wennberg (of Dartmouth Atlas fame) and asks "Where’s the Patient?" in healthcare anymore…You can also check out Marketplace.MD Blog to get your daily dose of health policy blog fodder….but those of you with a liberal bent might want to be ready for a barney!
 
Meanwhile, in many liberal blogs the old debate about single payer
versus other approaches to universal care is getting a run out.  At TPMcafe, Leif Wellington Haase wonders about
"Universal Health Care: Many Roads to Rome?" The piece argues that the
goal of universal coverage can be pursued through many means, not only through
insisting on a "single-payer only" strategy. On the same theme
at SignalHealth John Rodat’s Politics After Single Payer, is a piece about single-payer proponents struggling to reconcile their shared disdain for President Bush and Republican Congressional leadership with their confidence  in complete Federal control of healthcare financing in the US.  John also wrote, "A Tiny Technical Issue of Constitutional Significance" about the Deficit Reduction Act of 2005. The Act had many provisions related to health care, especially Medicare and Medicaid, but John argues that the most important issue is one of legislative procedure, an inconsistency between the House and Senate passed versions of and the cavalier manner in which the political leadership ignored a fundamental rule of lawmaking in the US.
Jonathan Cohn, New Republic health care reporter and author of a forthcoming book on health care sounds the alarm about rationing — the kind that already happens here in the U.S. Don’t look now, he says, but the problem is about to get worse.  
Meanwhile, at Healthy Policy young punkette Kate Steadman mulls over the potential problems of staying in an employer-based insurance framework.
 
There’s plenty more from Jonathan, Kate, Leif, Ezra Klein and plenty of others (including when he gets around to it your host at THCB) over at the “Drug Bill Debacle” table at TPMCafe. Those of you on the “free-market” end of the spectrum (or whatever passes for that these days) may have to gird up your loins before you venture over. I’ll leave the reader to decide whose policy is voodoo-based. 
 
Health care is though as much about business as it is about policy:
 
The business of health care is business
 
Tony Chen of Hospital Impact comments on the supposed 5 most dangerous trends for hospitals.  Could profitability problems close down 150,000 hospital beds in the next 6 years?
 
At Health Care Renewal, Roy Poses has a great article about Shalala and the janitors. To give it all away, the first irony is that the maintenance workers at the University of Miami medical center do not have health insurance provided by their employer. The second is that the university president, whose palatial university-supplied mansion and life-style were just written up in the New York Times Magazine, is Donna Shalala, former Secretary of Health and Human Services in the Clinton administration, a public advocate for universal health insurance. The third (and not noted except on Health Care Renewal) is that Shalala also sits on the board, and hence has fiduciary responsibility for, UnitedHealth Group, a for-profit managed care company whose stated mission includes improving access to health care.
 
David Williams at the Health Business Blog looks at the FDA report on the status of pharma companies’ post-marketing commitments. Although PhRMA says the report shows all is well, Public Citizen makes a solid argument for why that’s not the case.
 
At Managed Care Matters Health Wonk Review’s founder and guiding star Joe Paduda worries that rising health care costs are leading to increasing labor relations problems for manufacturers and service companies across the US. With premiums growing five times faster than wages, employers are trying to shift more of the financial burden onto workers. One of the better reform advocacy groups, the National Coalition for Healthcare Reform, has done an admirable job of presenting alternative solutions.

At Point of Law, insurance specialist Martin Grace of Georgia State looks at some current controversies over medical malpractice and concludes that the recent crisis is not just an artifact of the "insurance cycle", as some have contended; and that the leveling off of premiums in the past year should not be taken as a sign that our medical liability system has somehow reverted to health.

Dmitriy, the Publisher of The Medical Blog Network has looked into the firestorm caused by New York Times article "Why Doctors So Often Get It Wrong", noting that P4P is here to stay and now even AMA is getting with the program.

At THCB your host is not surprised that we have too many inefficient doctors, but predicts an untimely demise for a certain group of health service researchers if they don’t shut up about it. 
 
Meanwhile guesting in the same place, Brian Klepper is unimpressed by the chances of consumerism as being a savior for health care.  Don’t miss the excellent and long, long comments section.
Tech and mash
Some of the best in the health care IT world are in this section:

Shahid Shah, The Healthcare IT Guy, blogs about how we should all start using RSS for health/medical alerts and data sharing. In the posting he reminded us that today’s medical devices send out alerts using push-based approaches which are usually proprietary. He encourages software vendors to start providing RSS/ATOM feeds from their applications to help get non-safety-critical data out of their health IT systems because it’s easier to use, interoperable, and a cinch to deploy.

Tim Gee at Medical Connectivity reports on the creation of a health care advisory board for portable computing device vendor OQO. The OQO “pocketable” Windows computer could be the device that overcomes limitations that have held back the adoption of other devices like PDAs and Tablet computers.

MrHISTalk features an excellent article from Nurse Janus about the hellish life of a clinician going through a major install, and subsequent un-install. And of course most of the best gossip in the hospital IT world lives at that site.

Turning his hand to tech, Dmitriy of The Medical Blog Network reports from the CalRHIO Summit III, making sense of how capable are RHIOs of truly serving the interests of consumers. What is rhetoric and what is reality? He also writes about the tough talk dished out by Craig Barrett towards the healthcare industry and why this is the leading indicator of general public’s attitude towards the industry.

Guesting on THCB, hospital IT director Roy Johnson is not exactly impressed by the “highness” of the tech in health care IT.

Rod, on the Informaticopia Blog examines the implications of an announcement by UK universities that they will be changing their user authentication system from Athens to Shibboleth over the next few years. As the UK’s National Health Service currently uses the Athens system for its 1 million + staff it is likely that they will need to go the same way.

Rod would also like to give everyone a “heads up” about the HC2006 Blog from Europe’s Healthcare Computing Conference and Exhibition (which is sort of equivalent to HIMSS) on 20-22nd March. The blog will be an eclectic collection of news and views – as near to real time as we can get it – and offer the opportunity for those unable to attend to comment on the issues.
Meanwhile, if you are thinking of haranguing a journalist or a blogger about your company’s incredible new software product, Neil Versel’s Healthcare IT Blog tells you what not to do

Odds and ends
 
Last but not least are a few on unique health care issues that don’t fit so easily into other sections
 
Fard Johnmar at Envisioning 2.0 is currently holding a series of conversations about race and medicine with physicians, communicators, health policy experts and others. He is publishing these discussions to highlight new perspectives from a variety of people in the healthcare field about this important issue.  Dr. Sally Guttmacher, a noted public health expert, is the subject of the first interview. Fard will be posting interviews on this subject for the next few weeks — at least.  He is encouraging others within and without the healthcare blogosphere to contact him to be interviewed about this  topic. 
 
Guns at work – coming to a neighborhood near you? Julie Ferguson at Workers Comp Insider discusses the state-by-state push by the NRA to enact legislation that would override an employer’s policy prohibiting employees from keeping guns in their cars on company premises. Such measures have passed in a few states, but have hit a temporary roadblock in Florida. The NRA is determined to push on. The American Journal of Public Health recently published a study finding that murders are three times more likely to occur in workplaces that permit employees to carry weapons than in workplaces that prohibit all weapons.

 
Rita at the MSSP Nexus Blog (and no I still don’t know what that title means) is a little riled up about the practicalities and problems with board certification and credentialing as discussed in a recent JAMA article.
 
Meanwhile in one of my homes, away from THCB  Spot-on,  I’m very upset about the role of the Calvinists in our medicine cabinets. DEA employees reading this may not like what I say about them.

——

Thanks to all those who contributed, especially as I had them do it in a very vicious stringent format which almost everyone kept to. It really cuts down on the hosts work, so I recommend it to future hosts. You can see what I suggested for contributors here.

In two weeks Kate Steadman will  host HRW over at Healthy Policy.

THCB: A brief word about advertising and commercialization

This blog is never going to make me a fortune, but it may be within site of at least paying for its hosting fees. So following the familiar path of starting with Google Ads and moving on, I’m delighted to feature our first sponsored link from The Health Insurance Authority, which has a ton of good information about health insurance. It’s living in the far right margin in the new section called, amazingly enough “Sponsored Links”. 

Having a sponsored link is just one of the ways that if you have a product or service to sell you can — very inexpensively — reach the nearly 1,000 talented, brilliant and healthcare-focused people who visit THCB every day. You can click here to find out more about positional, inline and other advertising.. 

And of course I’d appreciate it if those of you who do visit went and paid my sponsors’ links a visit, bought a book or generally did something that’ll help brush a few crumbs from the Internet tabe THCB’s way.

And of course if you’re a health care organization interested in an entertaining and opinionated speaker to educate or dazzle your eployees, physicians or customers, or you are in need of a consultant to help you with a strategic and/or research project, please email me.

After all I don’t write this blog just for fun.

PHARMA: Pfizer, Rost and a look at off-label marketing

the whistleblowerPfizer has got a problem on its hands. Businessweek has had a chat with Peter Rost, the VP fired  for accusing Pfizer (and Pharmacia which it bought) of illegally off-label marketing of human growth hormone, the Pharmacia drug Genotropin, and of course for his views on reimportation (He thinks big Pharma should allow it – Big pharma opposes it).

Now in the big scheme of off-label marketing, this one is small potatoes. Big Pharma routinely violates both rules about marketing and promotion, and ends up having to pay fines or settlements on a frequent basis. Whistleblower suits abound. It’s part of the cost of doing business.

I too, have had an email "chat" with Peter Rost. He was in charge of marketing the product in question (although not in charge of sales) I asked him a few pointed questions, like did he inherit the "problem" or did it start when he was there?  And why did he keep going with the suit if Pfizer had already told the government about the problem?

Rost’s answers, which you can extract from the email trail on his lawyers web-site, are that this stuff was going on already when he got there, he pointed it out up the chain, but no one really dealt with it. He was concerned that he was potentially getting himself into trouble if Pharmacia didn’t come clean.

Meanwhile while Pfizer took over Pharmacia, Rost’s retention got messed up by the discovery that he was involved in suing his previous employer Wyeth, after which Pfizer suddenly decided that they didn’t want him. Meanwhile Rost wrote a memo blowing up the chain. Up until that point, according to Rost, Pfizer was doing the right thing but changed its tune and started pulling nasty corporate shenanigans. That included hiring a private detective to check Rost out, etc, etc.

Finally, according to Rost, Pfizer hand delivered a letter to the government (Rost called it an incomplete letter) the day before Rost formally filed his. If Rost is to be believed, he didn’t know that Pfizer was about to submit the letter and he had prepared his submission over time. In that case their timing appears just a little coincidental.

Now the government has declined to take part in the suit, meaning that they don’t think Rost’s case is that strong. Once that decision was made and the suit was uncovered, Rost was fired. Pfizer had kept him around doing nothing for a long time anyway, and hadn’t fired him because (I assume) they knew he was being a whistleblower, and there are strong laws about retaliation.

It seems to me that by piling on Rost, Pfizer has caused itself more trouble than if it had just come clean, blamed the whole thing on Fred Hassan & Pharmacia, and paid whatever it needed to to cut a deal with the  government as soon as it knew. After all it’s just part of the cost of doing business for big pharma. The whole thing is a lesson for risk management; one that you’d expect Pfizer already to have known.

Now they face a court case which at the least will leave them with some unwelcome publicity. Still better than the Feds forcing them to settle the Qui Tam….

POLICY: , Yet again caught up in the bluster of the drug war

Last week I wrote a piece at Spot-on criticizing the Calvinists in the medicine cabinet —  the theocratic fascists social conservatives who use the DEA to dictate prohibition and are increasingly bringing this irrational posturing into mainstream Republican (and thus government) policy. One thing I touched on is the suggestion that buying up the Afghan opium crop and using it for medicinal opiates might be one way of mitigating the problems of opium being the only viable cash crop there, with the consequence that the Taliban et al benefit from controlling it. Harvey Frey, an occasional contributor to THCB, trotted out some very tired and just plain wrong comments about the drug war and prohibition:

The idea that legalizing and licensing opium in Afghanistan will decrease the illegal opium trade is fantasy. Medical morphine sulphate is cheap – far cheaper than the far less effective modern concoctions of Big Pharma. Why would any opium farmer sell his crop cheaply to legitimate buyers, when he can get orders of magnitude higher prices from the black market?

So, if we go with a social libertarian policy, and decriminalize recreational opium use, how will we deal with the medical and social problems of the vastly increased numbers of users? We seem to have trouble paying for medical care now. How will we pay for care for millions of unemployed, uninsured addicts? Will we end up like China after the Opium Wars?

I wouldn’t usually go after this type of comment here, but Harvey’s arguments are flat out wrong. And someone needs to try to convert those people who are reachable. Harvey’s a scientist, so presumably he believes in data. So here goes:

a) the concept that the farmers get more for illegal poppies than legal ones is bullshit. I have met illegal opium farmers in Laos living in huts with mud floors, and legal ones in Tasmania living in fabulous farm houses. No question who’s getting more for their crop. The difference in cost is due to the middle men’s cut which is huge, again due to the illegality of the end product…which boosts its cost to the end user. And of course that boosts the amount available for criminals (including some very nasty ones in the Middle East). This is one occasion when I’m much rather J&J and GSK had the money. If we bought out the crop then the opium farmers would have the same amount of money and the criminals/terrorists would have much less. (Hey we do it with all kinds of other agricultural crops….)

b) there is no evidence that regulating and controlling the distribution of any illegal substance increases its use compared to attempting (and failing) to maintain its prohibition. Countries that have a harm reduction policy (Switzerland, Germany) for heroin/opiate/methadone have lower addiction and use rates than those with prohibitionist policies (the US). Kids in Amsterdam use marijuana at lower levels than those in the US, while it’s freely and legally available there, and theoretically illegal here.

More importantly the costs of addiction are not predominantly those of caring for the unemployed addicts. Several programs (again see Switzerland, Germany, and even the UK in the 1990s) show that legitimized maintenance programs allow addicts to maintain a normal life, including working and holding down jobs. BTW one of the forefathers of American surgery, William Halsted,  was a morphine addict, which never prevented him from practically inventing much modern medicine. It’s driving addicts into the black market and into the hands of criminal pushers that causes them to descend into the state Harvey suggests causes so much social malaise. Furthermore, in the only ever successful case of a steep decline in the use of a highly addictive drug (tobacco in the US in the last 30 years), its use rate fell because of education about its health effects. It was and is a legal product. And should stay that way. And we should treat other drug use the same way.

Finally, the societal costs of drug addiction absolutely pale in comparison to the societal costs of prohibition. We spend some $90 bn a year trying and failing to prohibit drugs in this country. There are fewer than 3 million drug addicts. So we’re already spending around $30,000 per addict on attempting to prohibit drugs–way more than the cost of supporting addicits even if they were not contributing at all to society and the economy. And that doesn’t count the cost to society such as the crime they commit to fund their drug habits, which is eliminated in Switzerland, Holland, etc.

The whole way we approach this — justified by the type of wrong information that Harvey puts out — is completely irrational, unless of course you are one of those in the prison-industrial complex benefiting from that spending. But of course the other supporters of the drug war, the theocratic fascists, glory in being post-enlightenment and completely irrational anyway.

THCB: Health Care Reform Challenge

death wears a smile todayHear Ye! Hear Ye! The first THCB Health Care Reform Competition is now officially (and finally) closed. 

Have THCB readers managed to come up with a creative solution to the problems facing the healthcare system that nobody else had of thought of yet?  Has a problem that has stumped the finest minds for generations been solved at last … and by a blog?

Perhaps. And perhaps not! See for yourself. Let the judging begin!

The official winners will be picked by Eric Novack and me, but you can comment/vote on entries in this thread. Nobel prizes will be awarded later if applicable.

 

POLICY: HSAs, what are they really?

Buried in this somewhat balanced article about HSAs which postulates that the healthy & wealthy may get most out of health-savings accounts, is this gem from a leading “free-marketer” and HSA advocate:

John Goodman, the president of the National Center for Policy Analysis in Dallas and an advocate of HSAs, said that the tax incentives are appropriate because the accounts serve two purposes. “This isn’t just a savings account,” he said. “It’s self-insurance for health care.”

Meanwhile, veteran Democratic Congressman Jim McDermott tells the other side of the coin. But it’s the same coin.

A bedrock principle of this nation is to pool our resources and share the risk, because it benefits us all. That’s why we collectively support police and fire departments, national defense and a host of other essential services. The alternative would turn back the clock to the early 20th century, when people were wiped out by one moment of misfortune.

Is HSA any different? No. HSAs would accelerate a trend that has seen the percentage of employers offering health insurance drop 15 percent during the Bush Administration. A HSA would be an incentive for employers to transfer more of the burden to the individual. The outcome is inevitable, even for forward thinking, employee-focused, responsible corporate citizens. How long can they last when the competition abandons providing health insurance?

So the left and the right agree—HSAs et al move us to self-insurance or self-pay for health care and away from the idea of pooling. Of course rational people think that for health care with its uneven distribution of risk and costs, that’s nuts. The right (or at least the honest right) just thinks that it’s all OK. But at least we’re all agreed on what it is.

POLICY/POLITICS: The swiftboating of single-payer?

Here’s my FierceHealthcare editorial today

Last year the most viewed article in Health Affairs was an article suggesting that 50% of bankruptcies in America were in some part related to medical costs. The article was written by a group led by two of the intellectual leaders of the single payer movement, Harvard professors David Himmelstein and Steffi Woolhandler. This week their findings were challenged by two Northwestern-affiliated researchers, David Dranove and Michael Millenson, who reviewed their data and claimed that the number was closer to 17%. They also suggested that the not as many of people declaring bankruptcy were as solidly middle class prior to their medical catastrophe as the Harvard group had suggested. Himmelstein et al shot back saying that the Dranove and Millenson had got their math wrong, and that they were lackeys for AHIP the health insurance industry group that sponsored their study — even though it was a peer reviewed article which AHIP funded but didn’t control. Some of their supporters accused Dranove and Millenson of "swift-boating".

Why is this obtuse academic dispute so important? Whatever the facts, and facts are very malleable in our political debates, the role of the middle class in health reform is vital. There is incontrovertible evidence that lower-income Americans have disproportionately higher health costs out of pocket than poorer people in other countries. But 100 years of history shows that politically this doesn’t matter too much. If it becomes accepted that middle-class, middle income Americans are equally vulnerable to financial catastrophe due simply to bad luck with their health, then the political discussion might shift. So this is one of those occasions where, as Keynes said, the scribblings of some (not-yet) defunct economist might actually matter in terms of politics and policy.

UPDATE:  If you haven’t had a chance yet, you can listen to this week’s podcast of my converstation with Millenson on this very topic. 

assetto corsa mods